Acurx Pharmaceuticals, Inc. SEC filings

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

1. ROUTINE8-KAcurx Pharmaceuticals, Inc.ACXP2d

   Acurx Pharmaceuticals holds annual meeting

   • 5,471,297 shares outstanding
   • 52.83% of shares voted
   • CohnReznick LLP ratified as auditors
2. ROUTINEEFFECTAcurx Pharmaceuticals, Inc.ACXPSep 18

   Registration declared effective

3. ROUTINE424B3Acurx Pharmaceuticals, Inc.ACXPSep 17

   Securities offering

4. NOTABLES-1Acurx Pharmaceuticals, Inc.ACXPSep 8

   Securities offering

5. ROUTINEARSAcurx Pharmaceuticals, Inc.ACXPSep 1

   Annual report to shareholders

6. ROUTINEDEFA14AAcurx Pharmaceuticals, Inc.ACXPSep 1

   Additional proxy materials

7. ROUTINEDEF 14AAcurx Pharmaceuticals, Inc.ACXPSep 1

   Proxy statement

8. NOTABLE10-QAcurx Pharmaceuticals, Inc.ACXPAug 13

   Quarterly report

9. ROUTINE424B3Acurx Pharmaceuticals, Inc.ACXPMay 12

   2 structured-note prospectuses

   Securities offering

   Show all 2

   • 424B3Securities offeringMay 12
   • 424B3Securities offeringMay 12
10. ROUTINEEFFECTAcurx Pharmaceuticals, Inc.ACXPMay 12

    Registration declared effective

11. ROUTINEEFFECTAcurx Pharmaceuticals, Inc.ACXPMay 12

    Registration declared effective

12. NOTABLE10-QAcurx Pharmaceuticals, Inc.ACXPMay 11

    Quarterly report

13. NOTABLES-1Acurx Pharmaceuticals, Inc.ACXPMay 4

    Securities offering

14. NOTABLES-1Acurx Pharmaceuticals, Inc.ACXPMay 4

    Securities offering

15. ROUTINEDAcurx Pharmaceuticals, Inc.ACXPApr 29

    Private placement notice

16. ROUTINE4Acurx Pharmaceuticals, Inc.ACXPApr 22

    8 insider filings

    Carl Sailer, insider filing for ACXP

    Show all 8

    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22
    • 4Insider filing for ACXPApr 22

    Carl Sailer, reporting

17. ROUTINE8-KAcurx Pharmaceuticals, Inc.ACXPApr 16

    Current report

18. ROUTINE424B5Acurx Pharmaceuticals, Inc.ACXPApr 16

    Securities offering

19. ROUTINES-8Acurx Pharmaceuticals, Inc.ACXPMar 12

    Employee stock plan registration

20. NOTABLE10-KAcurx Pharmaceuticals, Inc.ACXPMar 12

    Annual report

21. ROUTINE8-KAcurx Pharmaceuticals, Inc.ACXPMar 10

    Current report

22. ROUTINEEFFECTAcurx Pharmaceuticals, Inc.ACXPFeb 12

    Registration declared effective

23. ROUTINE424B3Acurx Pharmaceuticals, Inc.ACXPFeb 11

    Securities offering

24. NOTABLES-1Acurx Pharmaceuticals, Inc.ACXPFeb 2

    Securities offering

25. ROUTINEEFFECTAcurx Pharmaceuticals, Inc.ACXPJan 7

    Registration declared effective

26. ROUTINES-3/AAcurx Pharmaceuticals, Inc.ACXPDec 30, 2025

    Securities offering (amended)

27. ROUTINESCHEDULE 13G/AAcurx Pharmaceuticals, Inc.ACXPNov 14, 2025

    Acurx Pharmaceuticals, Inc. (ACXP) filed a Schedule 13G/A, reporting that ARMISTICE CAPITAL, LLC has decreased its beneficial ownership in the company to below 5%.

    ARMISTICE CAPITAL, LLC, filed by

28. NOTABLE10-QAcurx Pharmaceuticals, Inc.ACXPNov 12, 2025

    Quarterly report

29. ROUTINE424B3Acurx Pharmaceuticals, Inc.ACXPNov 10, 2025

    Securities offering

Older filings on EDGAR